| 产品详情 |
| Edit |   |
|---|
| Product Name | NAGLU, Recombinant, Human (Alpha-N-acetylglucosaminidase, N-acetyl-alpha-glucosaminidase, NAG, UFHSD1) |
|---|
| Description | MW: ~81kD. Highly Purified>95% by SDS-PAGE under reducing conditions. Human lysosomal A-N-acetylglucosaminidase is a hydrolase that catalyses the removal of terminal A-N-acetylglucosamine residues from heparan sulfate and heparin. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. Mucopolysaccharidosis types IIIA, C, and D are caused by mutations in other genes involved in the lysosomal degradation of heparan sulfate. Contin |
|---|
| Size | 0.02 mg |
|---|
| Concentration | 0.88 mg/ml |
|---|
| Applications | n/a |
|---|
| Other Names | [Naglu; alpha-N-acetylglucosaminidase; N-acetyl-glucosaminidase; alpha-N-acetylglucosaminidase, lysosomal; alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB)] |
|---|
| Gene, Accession, CAS # | Naglu, Gene ID: 27419, Accession: AAB88084.1 |
|---|
| Catalog # | MBS638019 |
|---|
| Price | |
|---|
| Order / More Info | NAGLU, Recombinant, Human (Alpha-N-acetylglucosaminidase, N-acetyl-alpha-glucosaminidase, NAG, UFHSD1) from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|